Market Research Logo

Acceleron Pharma, Inc. - Product Pipeline Review - 2016

Acceleron Pharma, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Acceleron Pharma, Inc. - Product Pipeline Review - 2016’, provides an overview of the Acceleron Pharma, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Acceleron Pharma, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Acceleron Pharma, Inc.
  • The report provides overview of Acceleron Pharma, Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Acceleron Pharma, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Acceleron Pharma, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Acceleron Pharma, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Acceleron Pharma, Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Acceleron Pharma, Inc.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Introduction
Global Markets Direct Report Coverage
Acceleron Pharma, Inc. Snapshot
Acceleron Pharma, Inc. Overview
Key Information
Key Facts
Acceleron Pharma, Inc. - Research and Development Overview
Key Therapeutic Areas
Acceleron Pharma, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Acceleron Pharma, Inc. - Pipeline Products Glance
Acceleron Pharma, Inc. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Acceleron Pharma, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Acceleron Pharma, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Acceleron Pharma, Inc. - Drug Profiles
luspatercept
Product Description
Mechanism of Action
R&D Progress
dalantercept
Product Description
Mechanism of Action
R&D Progress
sotatercept
Product Description
Mechanism of Action
R&D Progress
ACE-083
Product Description
Mechanism of Action
R&D Progress
ACE-1332
Product Description
Mechanism of Action
R&D Progress
ACE-2395
Product Description
Mechanism of Action
R&D Progress
ACE-2494
Product Description
Mechanism of Action
R&D Progress
ACE-2536
Product Description
Mechanism of Action
R&D Progress
ACE-2798
Product Description
Mechanism of Action
R&D Progress
ACE-3891
Product Description
Mechanism of Action
R&D Progress
ACE-661
Product Description
Mechanism of Action
R&D Progress
Acceleron Pharma, Inc. - Pipeline Analysis
Acceleron Pharma, Inc. - Pipeline Products by Target
Acceleron Pharma, Inc. - Pipeline Products by Route of Administration
Acceleron Pharma, Inc. - Pipeline Products by Molecule Type
Acceleron Pharma, Inc. - Pipeline Products by Mechanism of Action
Acceleron Pharma, Inc. - Recent Pipeline Updates
Acceleron Pharma, Inc. - Dormant Projects
Acceleron Pharma, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
ramatercept
Acceleron Pharma, Inc. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Acceleron Pharma, Inc., Key Information
Acceleron Pharma, Inc., Key Facts
Acceleron Pharma, Inc. - Pipeline by Indication, 2016
Acceleron Pharma, Inc. - Pipeline by Stage of Development, 2016
Acceleron Pharma, Inc. - Monotherapy Products in Pipeline, 2016
Acceleron Pharma, Inc. - Phase III, 2016
Acceleron Pharma, Inc. - Phase II, 2016
Acceleron Pharma, Inc. - Phase I, 2016
Acceleron Pharma, Inc. - Preclinical, 2016
Acceleron Pharma, Inc. - Pipeline by Target, 2016
Acceleron Pharma, Inc. - Pipeline by Route of Administration, 2016
Acceleron Pharma, Inc. - Pipeline by Molecule Type, 2016
Acceleron Pharma, Inc. - Pipeline Products by Mechanism of Action, 2016
Acceleron Pharma, Inc. - Recent Pipeline Updates, 2016
Acceleron Pharma, Inc. - Dormant Developmental Projects,2016
Acceleron Pharma, Inc. - Discontinued Pipeline Products, 2016
List of Figures
Acceleron Pharma, Inc. - Pipeline by Top 10 Indication, 2016
Acceleron Pharma, Inc. - Pipeline by Stage of Development, 2016
Acceleron Pharma, Inc. - Monotherapy Products in Pipeline, 2016
Acceleron Pharma, Inc. - Pipeline by Top 10 Target, 2016
Acceleron Pharma, Inc. - Pipeline by Top 10 Route of Administration, 2016
Acceleron Pharma, Inc. - Pipeline by Top 10 Molecule Type, 2016
Acceleron Pharma, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report